 |
|
|
| |
Dolutegravir Regimen Statistically Superior to Efavirenz/Tenofovir/Emtricitabine:
96-Week Results From the SINGLE Study (ING114467)
|
| |
| |
Reported by Jules Levin
CROI 2014 March 3-6 Boston, MA
S Walmsley1, J Berenguer2, M Khuong-Josses3, JM Kilby4, T Lutz5, D Podzamczer6, N Roth7, C Granier8, B Wynne9, K Pappa10
1University Health Network, Toronto, Canada; 2Hospital General Universitario Gregorio Maranon, Madrid, Spain; 3Hopital Delafontaine, Paris, France; 4Medical University of South Carolina, Charleston, SC; 5Infektiologikum Frankfurt, Frankfurt, Germany; 6Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain; 7Prahran Market Clinic, Melbourne, Australia; 8-10GlaxoSmithKline, 8London, United Kingdom; 9Philadelphia, PA; 10Research Triangle Park, NC
delphia, PA; 10Research Triangle Park, NC
|
| |
|
|
|
|
|
